Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REVErsing Airway Remodelling With Tezepelumab : a Protocol for a Double-blind Randomized Controlled Trial for Patients With Asthma

NCT05651841 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05651841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05651841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REVErsing Airway Remodelling With Tezepelumab : a Protocol for a Double-blind Randomized Controlled Trial for Patients With Asthma
Lead sponsor
University Hospital, Montpellier
Phase
Phase 3
Overall status
Completed
Start date
March 27, 2023
Completion date
June 23, 2026
Enrollment
90 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

airway remodelling, asthmatic